Checkpoint inhibitor-associated immune arthritis

Ann Rheum Dis. 2019 Jul;78(7):e68. doi: 10.1136/annrheumdis-2018-213470. Epub 2018 May 3.

Authors

Laurent Arnaud¹, Bénédicte Lebrun-Vignes², Joe-Elie Salem²

Affiliations

¹ Department of Rheumatology, Hôpitaux Universitaires de Strasbourg & INSERM UMRS-1109, Strasbourg, France.
² AP-HP, Pitié-Salpêtrière Hospital, Department ofPharmacology, CIC-1421, Pharmacovigilance Unit; INSERM, UMR ICAN 1166;Sorbonne Universités, UPMC Univ Paris 06, Faculty of Medicine; Institute ofCardiometabolism and Nutrition (ICAN), F-75013, Paris, France.

PMID: 29724725
DOI: 10.1136/annrheumdis-2018-213470

No abstract available

Keywords: autoimmune diseases; rheumatoid arthritis; systemic lupus erythematosus; treatment.

Publication types

Letter
Comment

MeSH terms

Arthritis, Rheumatoid*
Humans
Immune System Diseases*
Immunologic Factors
Neoplasms*
Prospective Studies

Substances

Immunologic Factors